6.75 CME Credits

4 February 2020
Riyadh Room, Za'abeel Hall 3, Dubai World Trade Centre

The conference will focus on national and global approaches to tackling AMR and how one can enable sustainable, effective and appropriate use of antimicrobial agents. Delegates will also get updates on emerging and re-emerging multi-drug resistant pathogens to improve microbiological analysis in the lab. It will highlight areas in bacteriology and clinical applications of microbes for the improvement of health.

Key topics:

  • Resource and method management 
  • Antimicrobial resistance (AMR) and Multi-drug resistant organisms (MDROs)
  • Molecular microbiology Updates in mycology & virology
  • Innovations and biotechnology moving micro forward 

Benefits of attending:

  • Understand how to manage a laboratory in a value-based model of healthcare
  • Discuss if auto verification can provide cost savings 
  • Learn more about the common problems and solutions faced by labs all over the world
  • Analyse how to manage quality and quality metrics in the laboratory


Dr Eiman Mokaddas, Professor & Chairperson, Department of Microbiology & Immunology, University Health Sciences Centre, Kuwait University, Kuwait City, Kuwait

Dr Adnan Alatoom, President, Emirates Society of Clinical Microbiology, Clinical Pathologist, Pathology & Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE 

Activity director:

Dr Fadi W. Abdul-Karim, Professor Emeritus, Cleveland Clinic Lerner School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA

Speaker Faculty:

Dr Diane C. Halstead, President, Global Infectious Disease Consultants, Jacksonville, Florida, USA

Dr Edet Udo, Department of Microbiology, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait

Dr Giovanni Sotgiu, Clinical Epidemiology and Medical Statistics
Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy

Dr Hafiz Ahmad, Assistant Professor of Microbiology, Clinical Microbiologist Department of Medical Microbiology & Immunology, RAK Medical and Health Sciences University, RAK Hospital, Ras al Khaimah, UAE 

Hadeel Alrashedi, Department of Medical Laboratories, College of Applied Medical Sciences, Department of Public Health, College of Public Health and Health Informatics, Qassim University, Buraydah, KSA

Dr Giovanni Sotgiu, Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy

Dr James H. Nichols, Professor of Pathology, Microbiology and Immunology; Medical Director, Clinical Chemistry and Point-of-Care Testing, Vanderbilt University School of Medicine, Nashville, Tennessee, USA

Prof Jean-Michel Pawlotsky, Professor of Medicine, University of Paris-Est, Creteil, France

Dr Kavita Diddi, General Secretary, Emirates Society of Clinical Microbiology, Specialist Microbiologist, Prime Healthcare
Group, Dubai, UAE

Lim Erin, Program Academic Committee Chair, Medical Laboratory Science, Higher Colleges of Technology, Assistant
Professor, Health Sciences Division, Higher Colleges of Technology, Abu Dhabi, UAE

Prof Dr Pavel Drevinek, Department of Medical Microbiology, Head of department, Department of Paediatrics, Director of cystic fibrosis centre, Charles University, Motol University Hospital, Praha, Czech Republic

Dr Stefan Weber, Consultant Microbiologist, SKMC, Clinical
Services - Medical Affairs, Sheikh Khalifa Medical City, Abu Dhabi, UAE

Theo Liebregts, Head of Bacteriology, Pamm Laboratories, Veldhoven, Netherlands

Dr Walaa Khater, Laboratory Consultant, World Health Organisation (WHO), Associate Professor, Ain Shams University Cairo, Egypt

Dr Wael Faroug Mohamed Elamin, Consultant Clinical Microbiologist and Infection Control Doctor, King's College Hospital, Dubai, UAE 

Prof Ziauddin Khan, Faculty of Medicine, Microbiology, Kuwait University, Kuwait City, Kuwait